Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03667781 · ClinicalTrials.gov registry record
Therapeutic Drug Monitoring of Cardiac Medications
A clinical trial, sponsored by University of Texas Southwestern Medical Center.
- Terminated
- Registry status
- 77
- Enrollment target
NCT03667781 is a clinical trial that was terminated before completion, run by University of Texas Southwestern Medical Center. The registered enrollment target is 77 participants.
The verdict
NCT03667781 was terminated before completion, sponsored by University of Texas Southwestern Medical Center.
- TERMINATED
- Registry status
- 77 participants
- Enrollment target
Study Summary
The investigators will interview patients and providers of patients who have hypertension and are seen in cardiology clinic about ways to discuss therapeutic drug monitoring with patients. The investigators will use these interviews to crease discussion tools to discuss therapeutic drug monitoring. The investigators will then draw one venous blood sample in a different group of patients who are seen in interventional clinic for 1 month followup after PCI. The investigators will assay this blood for therapeutic drug monitoring and will provide the results to their providers for discussion at their regularly scheduled followup cardiology visit. The investigators will have the patients and providers fill out a survey afterwards to determine how they viewed therapeutic drug monitoring.
Interventions
- DIAGNOSTIC_TEST Therapeutic drug monitoring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 77 participants |
| Start Date | 2018-08-01 |
| Est. Completion | 2023-05-14 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03667781
The ClinicalTrials.gov registry entry for NCT03667781 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 77 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Therapeutic drug monitoring is the first listed.
NCT03667781 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03667781 about?
NCT03667781 is a clinical study titled "Therapeutic Drug Monitoring of Cardiac Medications". The investigators will interview patients and providers of patients who have hypertension and are seen in cardiology clinic about ways to discuss therapeutic drug monitoring with patients. The investigators will use these interviews to crease discussion tools to discuss therapeutic drug monitoring. ...
What is the current status of trial NCT03667781?
This trial is currently terminated. The enrollment target is 77 participants. The study started on 2018-08-01. Estimated completion is 2023-05-14.
What interventions are being tested in trial NCT03667781?
The interventions under investigation include: Therapeutic drug monitoring (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03667781?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.